Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-01

HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors’ Phenotypic Susceptibility

Elliott R. Rodríguez-López, Pablo López, Yadira Rodríguez [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2013-8

Market-wide Herding and the Impact of Institutional Investors in the Indian Capital Market

M.V. Lakshman, Sankarshan Basu, R. Vaidyanathan

Journal of Emerging Market Finance

Free access

Announcement

First published 2019-1

Increased dose of Dolutegravir as a Potential Rescue Therapy in Multi-Experienced Patients

Davide Ferrari, Vincenzo Spagnuolo, Monica Manca [...]

Antiviral Therapy

Free access

Case report

First published 2011-2

Transmission of Integrase Strand-Transfer Inhibitor Multidrug-Resistant HIV-1: Case Report and Response to Raltegravir-Containing Antiretroviral Therapy

Benjamin Young, Signe Fransen, Kenneth S Greenberg [...]

Antiviral Therapy

Retricted access

Research article

First published 2020-4

Has the Global Financial Crisis Changed the Market Response to Credit Ratings? Evidence from an Emerging Market

Kaveri Krishnan, Sankarshan Basu, Ashok Thampy

Journal of Emerging Market Finance

Free access

Announcement

First published 2009-1

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes

Almoustapha-Issiaka Maïga, Isabelle Malet, Cathia Soulie [...]

Antiviral Therapy

Retricted access

Research article

First published 2025

Free Float,Stock Liquidity,and Stock Price Discounts: Evidence from India

Pankaj K. Agarwal, H. K. Pradhan

Journal of Emerging Market Finance

Retricted access

Research article

First published 2009-04

Are Competitive Rating Agencies Efficient?

Bappaditya Mukhopadhyay

Journal of Emerging Market Finance

Free access

Case report

First published 2011-8

Long-Lasting Persistence of Integrase Resistance Mutations in HIV-2-Infected Patients after Raltegravir Withdrawal

the French ANRS HIV-2 Cohort (ANRS CO 05), Charlotte Charpentier, Lucile Larrouy [...]

Antiviral Therapy

Open access

Research article

First published 2016-07

Q148N,a Novel Integrase Inhibitor Resistance Mutation Associated with Low-Level Reduction in Elvitegravir Susceptibility

Vici Varghese, Benjamin A. Pinsky, Darvin S. Smith [...]

AIDS Research and Human Retroviruses

Search results